Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Tolerance to marijuana: heart rate and subjective "high".

Nowlan R, Cohen S.

Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):550-6.

PMID:
913022
3.

Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.

Heishman SJ, Huestis MA, Henningfield JE, Cone EJ.

Pharmacol Biochem Behav. 1990 Nov;37(3):561-5.

PMID:
1965045
4.

Marijuana consumption and tolerance to physiological and subjective effects.

Babor TF, Mendelson JH, Greenberg I, Kuehnle JC.

Arch Gen Psychiatry. 1975 Dec;32(12):1548-52.

PMID:
1200773
5.

Preference for high- versus low-potency marijuana.

Chait LD, Burke KA.

Pharmacol Biochem Behav. 1994 Nov;49(3):643-7.

PMID:
7862719
6.

Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory.

Miller L, Cornett T, Drew W, McFarland D, Brightwell D, Wikler A.

Pharmacology. 1977;15(3):268-75.

PMID:
325580
7.

Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.

Lau RJ, Tubergen DG, Barr M Jr, Domino EF, Benowitz N, Jones RT.

Science. 1976 May 21;192(4241):805-7.

PMID:
1265484
8.

Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.

Heishman SJ, Stitzer ML, Yingling JE.

Pharmacol Biochem Behav. 1989 Sep;34(1):173-9.

PMID:
2560548
9.

Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.

Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2002 Dec;164(4):407-15. Epub 2002 Sep 14.

PMID:
12457271
10.

Breathhold duration and response to marijuana smoke.

Zacny JP, Chait LD.

Pharmacol Biochem Behav. 1989 Jun;33(2):481-4.

PMID:
2554344
11.

A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.

Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Sarne Y, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E.

J Psychopharmacol. 2008 Jun;22(4):441-51. doi: 10.1177/0269881108088194.

PMID:
18635724
12.

'Hangover' effects the morning after marijuana smoking.

Chait LD, Fischman MW, Schuster CR.

Drug Alcohol Depend. 1985 Jun;15(3):229-38.

PMID:
2992898
13.

Effects of delta 9-tetrahydrocannabinol and social context on marijuana self-administration by humans.

Kelly TH, Foltin RW, Mayr MT, Fischman MW.

Pharmacol Biochem Behav. 1994 Nov;49(3):763-8.

PMID:
7862735
14.

Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.

Purnell WD, Gregg JM.

Ann Ophthalmol. 1975 Jul;7(7):921-3.

PMID:
1147519
15.

Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.

Cooler P, Gregg JM.

South Med J. 1977 Aug;70(8):951-4.

PMID:
329423
16.

Social effects of marijuana use in a recreational setting.

Babor TF, Mendelson JH, Uhly B, Kuehnle JC.

Int J Addict. 1978 Aug;13(6):947-59.

PMID:
730405
17.

Abstinence symptoms following oral THC administration to humans.

Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 1999 Feb;141(4):385-94.

PMID:
10090646
18.

Are choice and self-administration of marijuana related to delta 9-THC content?

Kelly TH, Foltin RW, Emurian CS, Fischman MW.

Exp Clin Psychopharmacol. 1997 Feb;5(1):74-82.

PMID:
9234042
19.

Effects of marijuana smoking on subjective ratings and tobacco smoking.

Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR.

Pharmacol Biochem Behav. 1986 Sep;25(3):659-65.

PMID:
3774833
20.

Acute and residual effects of marijuana in humans.

Fant RV, Heishman SJ, Bunker EB, Pickworth WB.

Pharmacol Biochem Behav. 1998 Aug;60(4):777-84.

PMID:
9700958

Supplemental Content

Support Center